4D Molecular Therapeutics
FDMT
#7584
Rank
NZ$0.51 B
Marketcap
$11.15
Share price
9.17%
Change (1 day)
-66.07%
Change (1 year)

Revenue for 4D Molecular Therapeutics (FDMT)

Revenue in 2024 (TTM): NZ$0.02 Million

According to 4D Molecular Therapeutics's latest financial reports the company's current revenue (TTM ) is NZ$0.03 Million. In 2023 the company made a revenue of NZ$32.76 Million an increase over the revenue in the year 2022 that were of NZ$4.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for 4D Molecular Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) NZ$0.02 M-99.91%
2023 NZ$32.76 M565.09%
2022 NZ$4.92 M-81.34%
2021 NZ$26.4 M39.98%
2020 NZ$18.86 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA